Scientific Advisory Board


Karen Gelmon, MD

Karen Gelmon, Professor, Medicine, University of British Columbia;
Karen Gelmon, Senior Scientist, Medical Oncologist, BC Cancer Agency, Vancouver Centre;
Karen Gelmon, Head, Investigational Drug Program, Experimental Therapeutics, Department of Medical Oncology, BC Cancer Agency

Eric Lander, PhD

Eric S. Lander, Professor of Biology, Massachusetts Institute of Technology (MIT);
Eric S. Lander, Founding Director, Broad Institute;
Eric S. Lander, Member of, Whitehead Institute for Biomedical Research, MIT;
Eric S. Lander, Professor of Systems Biology, Harvard Medical School

James Allison, PhD

James Allison, Chair, Immunology, The University of Texas MD Anderson Cancer Center

Patricia Ganz, MD

Patricia Ganz, Distinguished University Professor, David Geffen School of Medicine at UCLA;
Patricia Ganz, Director, Jonsson Comprehensive Cancer Center Los Angeles, California

David Mankoff, MD

David Mankoff, Professor Radiology, Medicine and Bioengineering, University of Washington

Michael Morin, PhD

Michael J. Morin, PhD, CEO and Founder, Supportive Therapeutics, LLC

Homer Pearce, PhD

Homer Pearce, Board of Directors (Retired), Eli Lilly and Company;
Homer Pearce, Director, Sunesis Pharmaceuticals Inc.

Dennis Sgroi, MD

Dennis Sgroi, Associate Pathologist, Director of Breast Pathology and Associate Professor of Pathology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts

George W. Sledge, MD

George W. Sledge, Ballvé-Lantero Professor of Oncology, Co-Director, Breast Cancer Program, Indiana University Cancer Care Center;
George W. Sledge, Professor of Medicine and Pathology, Indiana University School of Medicine